Samarkanova, D, Martin, S, Bisbe, L, Puig, J, Calatayud-Pinuaga, M, Rodriguez, L, Azqueta, C, Coll, R, Casaroli-Marano, R, Madrigal, A, Rebulla, P, Querol, S, Barcelona Cbed Study Grp. Clinical evaluation of allogeneic eye drops from cord blood platelet lysate. Blood Transfusion. 2021; 19(4)DOI:10.2450/2020.0130-20. PMID:33085593. IF:5.752(Q2/4D).

Piteira, AR, Bofill-Rodenas, AM, Farinas, O, Tabera, J, Vilarrodona, A. Lessons Learned From SARS-CoV-2 Pandemic in Donation and Tissue Banking Activities: Key Takeaways. TRANSPLANTATION. 2021; 105(7)DOI:10.1097/TP.0000000000003716. PMID:34019361. IF:5.385(Q1/2D).

Martínez, IR, Avendaño-Solá, C, Da Ros, CV, Llobet, AB, Erce, JAG, Fraile, MIG, Domínguez, LG, Andrés, IV, Velasco, JA, Rodríguez, VPG, Contreras, E, Uranga, SU, Herraiz, ALP, Jimenez-Marco, T, Pérez, AMO, Rodríguez, JLA, Pérez-Olmeda, M, Ramos-Martínez, A, Velasco-Iglesias, A, Cabrera, JLB, Duarte, RF. Factors related to the development of high antibody titres against SARS-CoV-2 in convalescent plasma donors from the ConPlas-19 trial. VOX SANGUINIS. 2024; 119(1)DOI:10.1111/vox.13561. PMID:37986640. IF:1.600(Q3/7D).

Regalado-Artamendi, I, Garcia-Fasanella, M, Medina, L, Fernandez-Sojo, J, Esquirol, A, Garcia-Cadenas, I, Martino, R, Briones, J, Sierra, J, Novelli, S. Age, CD34+cell dose, conditioning and pre-transplant cytopenias can help predict transfusion support in lymphoma patients undergoing autologous stem cell transplantation. VOX SANGUINIS. 2023; 118(8)DOI:10.1111/vox.13486. PMID:37356813. IF:1.800(Q3/7D).

Fernandez-Sojo J., Delgadillo J., Vives J., Rodriguez L., Mendoza A., Azqueta C., Garcia-Buendia A., Valdivia E., Martorell L., Rubio-Lopez N., Linares M., Alonso S., Ancochea A., Garcfa-Rey, E, García-Muñoz N., Medina L., Querol S.. A hub-and-spoke model to deliver effective access to chimeric antigen receptor T-cell therapy in a public health network: the Catalan Blood and Tissue Bank experience. CYTOTHERAPY. 2023; 25(1)DOI:10.1016/j.jcyt.2022.07.011. PMID:36041984. IF:3.700(Q1/3D).

Izquierdo, CP, Mingot-Castellano, ME, Fuentes, AEK, Peinado, JGA, Cid, J, Jimenez, MM, Valcarcel, D, Gomez-Segui, I, de la Rubia, J, Martin, P, Goterris, R, Hernandez, L, Tallon, I, Varea, S, Fernandez, M, Garcia-Munoz, N, Vara, M, Zarzoso, MF, Garcia-Candel, F, Paciello, ML, Garcia-Garcia, I, Zalba, S, Campuzano, V, Gala, JM, Estevez, JV, Jimenez, GM, Lorenzo, JLL, Arias, EG, Freiria, C, Sole, M, Idrovo, LFA, Castellet, JCH, Cruz, N, Lavilla, E, PTrez-Montana, A, Atucha, JA, Beltran, MEM, Macias, JRM, Salinas, R, del Rio-Garma, J. Real-world effectiveness of caplacizumab vs the standard of care in immune thrombotic thrombocytopenic purpura. Blood Advances. 2022; 6(24)DOI:10.1182/bloodadvances.2022008028. PMID:35930694. IF:7.500(Q1/2D).

Fernandez-Sojo, J, Horton, R, Cid, J, Azqueta, C, Garcia-Buendia, A, Valdivia, E, Martorell, L, Rubio-Lopez, N, Codinach, M, Aran, G, Marsal, J, Mussetti, A, Martino, R, Diaz-de-Heredia, C, Ferra, C, Valcarcel, D, Linares, M, Ancochea, A, Garcia-Rey, E, Garcia-Munoz, N, Medina, L, Carreras, E, Villa, J, Lozano, M, Gibson, D, Querol, S. Leukocytapheresis variables and transit time for allogeneic cryopreserved hpc: better safe than sorry. BONE MARROW TRANSPLANTATION. 2022; 57(10)DOI:10.1038/s41409-022-01750-2. PMID:35804055. IF:4.800(Q1/2D).

Fernandez-Sojo, J, Cid, J, Azqueta, C, Valdivia, E, Martorell, L, Codinach, M, Marsal, J, Mussetti, A, Esquirol, A, Trabazo, M, Benitez, MI, Ferra, C, Fox, ML, Linares, M, Alonso, E, Garcia-Rey, E, Garcia-Munoz, N, Medina, L, Castillo-Flores, N, Vall-Llovera, F, Garcia, A, Pinacho, A, Talarn, C, Arroba, JG, Coll, R, Santos, M, Valero, O, Carreras, E, Lozano, M, Querol, S. Post thawing viable CD34+Cells dose is a better predictor of clinical outcome in lymphoma patients undergoing autologous stem cell transplantation. BONE MARROW TRANSPLANTATION. 2022; 57(8)DOI:10.1038/s41409-022-01722-6. PMID:35614316. IF:4.800(Q1/2D).